676493 Sigma-AldrichVEGF Inhibitor, Flt₂₋₁₁ - Calbiochem
The VEGF Inhibitor, Flt2-11 controls the biological activity of VEGF. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
More>> The VEGF Inhibitor, Flt2-11 controls the biological activity of VEGF. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Less<<同義語: NITVTLKKFPL, VEGFR Tyrosine Kinase Inhibitor X, VEGFR1 Kinase Inhibitor I
お勧めの製品
概要
| Replacement Information |
|---|
主要スペック表
| Empirical Formula |
|---|
| C₆₁H₁₀₄N₁₄O₁₅ |
価格&在庫状況
| カタログ番号 | 在庫状況 | 包装 | Qty/Pk | 価格 | 数量 | |
|---|---|---|---|---|---|---|
| 676493-1MGCN |
|
樹脂アンプル | 1 mg |
|
— |
| References | |
|---|---|
| References | Tan, D.C., et al. 2001. FEBS Lett. 494, 150. |
| Product Information | |
|---|---|
| ATP Competitive | N |
| Declaration | Sold under license of U.S. Patent 6,200,954. |
| Form | White lyophilized solid |
| Formulation | Supplied as a trifluoroacetate salt. |
| Hill Formula | C₆₁H₁₀₄N₁₄O₁₅ |
| Chemical formula | C₆₁H₁₀₄N₁₄O₁₅ |
| Hygroscopic | Hygroscopic |
| Reversible | N |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | VEGF |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Peptide Sequence | H-Asn-Ile-Thr-Val-Thr-Leu-Lys-Lys-Phe-Pro-Leu-OH |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| カタログ番号 | GTIN |
| 676493-1MGCN | 04055977183696 |
Documentation
VEGF Inhibitor, Flt₂₋₁₁ - Calbiochem (M)SDS
| タイトル |
|---|
VEGF Inhibitor, Flt₂₋₁₁ - Calbiochem 試験成績書(CoA)
| タイトル | ロット番号 |
|---|---|
| 676493 |
参考資料
| 参考資料の概要 |
|---|
| Tan, D.C., et al. 2001. FEBS Lett. 494, 150. |



